News & Updates
Filter by Specialty:
What are the ideal thresholds for ASTP, toe-brachial index in diabetic foot screening?
In diabetic foot screening (DFS), both absolute systolic toe pressure (ASTP) and toe-brachial index (TBI) can detect ankle-brachial pressure index (ABPI)-determined peripheral arterial disease (PAD), results of a Singapore study have shown. The optimal threshold values derived from a multiethnic Asian diabetic population are <0.7 for TBI and <95.5 mm Hg for ASTP.
What are the ideal thresholds for ASTP, toe-brachial index in diabetic foot screening?
19 Apr 2022Higher dietary inflammation potential linked to polycystic ovary syndrome
Women who consume foods with greater inflammation potential in high amounts are more likely to have polycystic ovary syndrome (PCOS), a study has found.
Higher dietary inflammation potential linked to polycystic ovary syndrome
18 Apr 2022Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients
In patients with type 2 diabetes, consuming fruits and engaging in physical activity can reduce the risk of all-cause, cardiovascular disease, and stroke mortality, a study reports.
Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients
16 Apr 2022Obesity med cessation more likely after RYGB than sleeve gastrectomy
Patients who are on obesity-related medications before undergoing bariatric surgery may be more likely to discontinue their medications and less likely to restart them after undergoing Roux-en-Y gastric bypass (RYGB) than laparoscopic sleeve gastrectomy (LSG), a recent study has shown.
Obesity med cessation more likely after RYGB than sleeve gastrectomy
15 Apr 2022Elevated BMI may up recurrent AF risk
Among patients who had previously undergone ablation for atrial fibrillation (AF), the risk of recurrent AF increased with rising body mass index (BMI), according to a study from Denmark presented at EHRA 2022.
Elevated BMI may up recurrent AF risk
13 Apr 2022Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
07 Apr 2022SGLT2i lowers serum urate regardless of diabetes status
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) can keep serum urate levels low in patients with and without diabetes, according to a recent Singapore study.